摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-双(2-恶唑啉基)苯 | 101614-49-7

中文名称
1,3-双(2-恶唑啉基)苯
中文别名
——
英文名称
1,3-bis(2-oxazolinyl)benzene
英文别名
1,3-bis(oxazol-2-yl)benzene;1,3-Bis(2-oxazolyl)benzene;2-[3-(1,3-oxazol-2-yl)phenyl]-1,3-oxazole
1,3-双(2-恶唑啉基)苯化学式
CAS
101614-49-7
化学式
C12H8N2O2
mdl
——
分子量
212.208
InChiKey
XWGBGCDTDXIECR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    395.2±52.0 °C(Predicted)
  • 密度:
    1.233±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    52.1
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    六氟磷酸银1,3-双(2-恶唑啉基)苯甲醇 为溶剂, 反应 0.08h, 以36%的产率得到[Ag2(1,3-bis(2-oxazolinyl)benzene)2(acetonitrile)2](PF6)2
    参考文献:
    名称:
    Silver(I) complexes with oxazoline-containing bidentate ligands: Syntheses, structures and properties
    摘要:
    Six new coordination complexes [Ag-2(L)(2)](NO3)(2) (1), [Ag-2(L)(2)](ClO4)(2) (2), [Ag-3(L)(4)](SbF6)(3) (3), [Ag-2(L)(2)(CH3CN)(2)](PF6)(2) (4), [Ag-2(L)(2)(SO3CH3)(2)](CH3OH)(2) (5) and [Ag-2(L)(2)(SO3CF3)(2)] (6) were successfully synthesized by reactions of 1,3-bis(2-oxazolinyl) benzene (L) with different Ag(I) salts under the same reaction conditions. Complexes 1 and 2 have the same 16-membered ring structures, which are extended by Ag center dot center dot center dot O weak interactions and hydrogen bonds to form 3D frameworks. Complex 3 containing two- and four-coordinated Ag(I) atoms has two inter-connected 16-membered rings which are linked together by SbF6 to form a 3D framework. In complex 4, the Ag(I) is three-coordinated by two N atoms from the L ligands and one N atom from acetonitrile solvent and the structure of 4 is also a 16-membered ring. Complexes 5 and 6 have similar 16-member ring structure, and the anions coordinate with Ag(I) atoms. The results reveal that anions can influence on the structure of the complexes. Furthermore, the complexes were characterized by electrospray mass spectrometry. (c) 2012 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.ica.2012.06.035
  • 作为产物:
    描述:
    参考文献:
    名称:
    DDQ诱导杂环的脱氢对C ?C双键形成:2-噻唑和2-恶唑的合成
    摘要:
    像牛一样强: 2-噻唑和2-恶唑是通过2-噻唑啉和2-恶唑啉的氧化反应形成的,不需要在C4和C5位置处有取代基。DDQ在此转化过程中起氧化剂的作用,并且不需要金属。该通用步骤显示出良好的官能团耐受性,并以中等至极好的收率提供了各种2-噻唑和2-恶唑。
    DOI:
    10.1002/asia.201300267
点击查看最新优质反应信息

文献信息

  • Polymeric Compounds And Methods Of Making And Using The Same
    申请人:Fan Xiaodong
    公开号:US20140308317A1
    公开(公告)日:2014-10-16
    The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, malaria, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; killing or inhibiting the growth of a Plasmodium species; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.
    本公开提供化合物或其药学上可接受的盐,用于抑制微生物的生长;治疗患有微生物感染,疟疾,口腔炎,眼部感染,耳部感染,癌症或结核分枝杆菌感染的哺乳动物;杀死或抑制疟原虫的生长;抑制结核分枝杆菌的生长;调节哺乳动物的免疫反应;或拮抗非分散肝素,低分子量肝素肝素/低分子量肝素生物
  • [EN] POLYCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] COMPOSÉS POLYCYCLIQUES ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
    申请人:CELLCEUTIX CORP
    公开号:WO2014093225A3
    公开(公告)日:2014-08-07
  • Verfahren zur Herstellung von Phenylenbisoxazolinen
    申请人:Degussa GmbH
    公开号:EP1548012B1
    公开(公告)日:2007-10-03
  • BELENKIJ, L. I.;CHESKIS, M. A.;ZVOLINSKIJ, V. P.;OBUXOV, A. E., XIMIYA GETEROTSIKL. SOED., 1986, N 6, 826-836
    作者:BELENKIJ, L. I.、CHESKIS, M. A.、ZVOLINSKIJ, V. P.、OBUXOV, A. E.
    DOI:——
    日期:——
  • HEISSHÄRTENDE MASSEN
    申请人:Henkel Kommanditgesellschaft auf Aktien
    公开号:EP0556211A1
    公开(公告)日:1993-08-25
查看更多